Skip to main content

Morning Overview

Period tracker Flo will let users link cycle data with Fitbit and Pixel Watch readings early next year

Flo, the cycle-tracking app used by more than 80 million women every month, will begin syncing with Google Health early next year. Under a multi-year partnership announced Oct. 12, Flo cycle records can be linked with readings from Fitbit and Pixel Watch devices, and Google Health data can flow back into Flo. Every transfer is designed to be opt-in, with consent given separately for each type of data and each purpose.

Free daily tech email: Get Techpresso, the free daily email with the most interesting tech news and insights, read by 400,000+ professionals from Google, Apple and OpenAI.

Get Techpresso free →

We may earn a commission if you sign up.

Cycle history is among the most personal categories of health information a person can generate, so the rules for who sees it and what it can be used for are a central part of the announcement. Dr. Nichole Young-Lin, clinician lead for women’s health at Google, wrote the post laying out four pillars for the work: app syncing, coaching, joint research and new products built around wearable hardware.

Flo syncing with Google Health metrics

The first pillar is the one with a date attached. According to the Google Health blog post, starting early next year users will be able to sync the Flo app with Google Health, and with consent Flo cycle data can be linked with metrics such as resting heart rate, heart rate variability, skin temperature and sleep stages. Those are the same overnight and daily signals that wearables already collect, so pairing them with logged period dates is meant to give both apps a fuller picture of how the body changes across a cycle.

Google Health already offers basic cycle features of its own. Users can log cycle dates and symptoms, then view period predictions and cycle phases either on a wrist device such as the Google Fitbit Edge or in the Google Health app, and a Google Health Premium subscription adds cycle-aware coaching. The partnership builds on that foundation rather than replacing it, since the Flo link is described as an addition to features the platform already carries.

Opt-in consent and the advertising ban

Privacy terms carry much of the weight in this deal. The experience uses what Google describes as a strict opt-in model: data moves between the two apps only with explicit permission, that permission is requested separately for each data type and purpose, and users can withdraw it at any time. Google also says Flo data shared with Google Health will never be used for advertising or sold, a commitment that speaks directly to long-running worries about reproductive health data ending up in ad profiles. Google lays out its wider approach on its page about opt-in data sharing across devices.

A second limit covers third parties. Flo data will not be made available to other apps or developers through Google’s health platforms, so the link runs between Flo and Google Health only rather than opening a new feed for the wider app ecosystem.

The fine print also keeps expectations modest. The women’s health feature provides estimates and is described as a general wellness feature only, and Google states it should not be used for contraception, conception or other medical purposes. Coaching features require a Google Health Premium subscription that is sold separately, plus the Google Health app and an internet connection, and availability varies by device and region.

Coaching, research and new hardware

The second pillar feeds Flo data into the Google Health Coach. For subscribers to Premium, the Coach is meant to connect cycle, sleep and recovery data to produce guidance, including advice tied to cycle health and perimenopause. Because the Coach already draws on sleep and recovery readings, adding cycle phase gives it a way to explain why a hard week of training or a poor night of sleep might look different at different points in a month.

Research is the third pillar. Per the joint press release, the two companies plan studies on underserved topics that may include perimenopause, polyendocrine metabolic ovarian syndrome (PMOS), pregnancy and postpartum recovery. These are areas where consumer wearables have historically offered little, and the announcement does not name study sizes, timelines or academic partners, so details will have to come later.

The fourth pillar is hardware. Flo and Google plan products designed for women that combine Flo’s health insights and algorithms with Google’s wearable sensors. The devices named in the announcement are the Google Fitbit Air, the Pixel Watch 5 and the Fitbit Edge, though the post says the features are available on select devices rather than across the whole lineup.

For now the concrete commitment is the early-next-year syncing window, with no exact launch date given. Anyone who tracks a cycle in Flo and wears one of the supported devices will have a choice to make when the option arrives, and the opt-in design means nothing moves unless that choice is made. The advertising and developer-access limits are the terms most likely to be tested once real users start linking accounts, and the research results, if they materialize, will show whether the combination yields anything beyond convenience.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.


More from Morning Overview

Morning Overview is reader-supported. Some links in our articles are affiliate links, and we may earn a commission at no extra cost to you. As an Amazon Associate I earn from qualifying purchases. Full disclosure.